Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kimball

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 4, 2015
Design, synthesis, and in vivo activity of novel inhibitors of delta-5 desaturase for the treatment of metabolic syndromeSimon D P Baugh, Praveen K Pabba, Joseph Barbosa, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664Jagabandhu Das, S David Kimball, Steven E Hall, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2015
The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disordersYingzhi Bi, Carolyn D Dzierba, Cynthia Fink, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitorsHaihong Jin, Giovanni Cianchetta, Arokiasamy Devasagayaraj, et al.
Journal of Neurointerventional Surgery|July 19, 2023
Robotic Diagnostic Cerebral Angiography: A Multicenter Experience of 113 PatientsCharles Beaman, Ayushi Gautam, Catherine Peterson, et al.
Journal of Medicinal Chemistry|June 19, 2008
Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disordersZhi-Cai Shi, Arokiasamy Devasagayaraj, Kunjian Gu, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinaseJames E Tarver, Theodore C Jessop, Marianne Carlsen, et al.
Journal of Medicinal Chemistry|October 17, 2009
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucomaBryce A Harrison, N Andrew Whitlock, Michael V Voronkov, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2015
Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88Carolyn D Dzierba, Yingzhi Bi, Bireshwar Dasgupta, et al.
Journal of Medicinal Chemistry|November 25, 2010
Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)Jeffrey T Bagdanoff, Michael S Donoviel, Amr Nouraldeen, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|August 4, 2015
Design, synthesis, and in vivo activity of novel inhibitors of delta-5 desaturase for the treatment of metabolic syndromeSimon D P Baugh, Praveen K Pabba, Joseph Barbosa, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664Jagabandhu Das, S David Kimball, Steven E Hall, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2015
The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disordersYingzhi Bi, Carolyn D Dzierba, Cynthia Fink, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitorsHaihong Jin, Giovanni Cianchetta, Arokiasamy Devasagayaraj, et al.
Journal of Neurointerventional Surgery|July 19, 2023
Robotic Diagnostic Cerebral Angiography: A Multicenter Experience of 113 PatientsCharles Beaman, Ayushi Gautam, Catherine Peterson, et al.
Journal of Medicinal Chemistry|June 19, 2008
Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disordersZhi-Cai Shi, Arokiasamy Devasagayaraj, Kunjian Gu, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinaseJames E Tarver, Theodore C Jessop, Marianne Carlsen, et al.
Journal of Medicinal Chemistry|October 17, 2009
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucomaBryce A Harrison, N Andrew Whitlock, Michael V Voronkov, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2015
Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88Carolyn D Dzierba, Yingzhi Bi, Bireshwar Dasgupta, et al.
Journal of Medicinal Chemistry|November 25, 2010
Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)Jeffrey T Bagdanoff, Michael S Donoviel, Amr Nouraldeen, et al.
Pageof 5